Trial intelligence / Profile preview

Vitamin D in Non-Cystic Fibrosis Bronchiectasis

NCT02507843Phase 4Unknown

Sponsor
Shanghai Pulmonary Hospital
Start
Jan 2015
Primary completion
Dec 2016
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Non-cystic fibrosis bronchiectasis (NCFB) comparing Vitamin D group with Placebo group (2 arms). Primary endpoint: Time to first acute exacerbation at 1 year. Status: unknown.

02

Drugs

vitamin d
03

Conditions

Non-cystic fibrosis bronchiectasis (NCFB)

Beyond the preview

Go deeper on NCT02507843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02507843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call